查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617716

止血劑市場：按類型、配方和應用分類 - 2025-2030 年全球預測

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年止血劑市值為32.3億美元，預計到2024年將達到34.2億美元，複合年成長率為5.65%，到2030年將達到47.5億美元。

止血劑的範圍和定義是指在手術或創傷環境中透過促進血液凝固來止血的醫療設備和物質。止血劑在擇期和緊急外科手術中對於改善患者的復原時間和結果至關重要，特別是在心血管手術、創傷治療和某些類型的器官移植中。最終用途包括醫院、門診手術中心、專科診所以及全球軍事和創傷中心日益成長的需求。根據市場洞察，止血劑市場主要是由外科手術的增加以及醫療基礎設施的進步（尤其是在新興國家）推動的。開發生物分解性分解止血劑和適用於微創手術的產品等創新為公司擴大產品範圍提供了潛在機會。關鍵的成長要素包括人口老化、需要手術介入的慢性疾病的增加以及發展中地區醫療保健支出的增加。然而，仍然存在巨大的限制，例如嚴格的監管要求、潛在的副作用以及先進止血產品的高價格，這可能會阻礙市場的成長。此外，來自替代創傷護理和止血產品的競爭可能會對市場擴張產生不利影響。創新的最佳領域包括開發生物相容性更好、更快起效且副作用更少的下一代止血劑，以及投資研究探索止血劑在新外科手術中的使用。此外，創建永續且具有成本效益的解決方案可以擴大資源匱乏環境中的訪問範圍並提供開拓的市場潛力。市場競爭激烈，保持領先需要與研究機構建立策略聯盟和合作。總之，雖然機會比比皆是，但企業必須駕馭監管環境，投資研發以應對挑戰，並有效抓住成長機會。

主要市場統計
基準年[2023] 32.3億美元
預測年份 [2024] 34.2億美元
預測年份 [2030] 47.5億美元
複合年成長率（%） 5.65%

市場動態：揭示快速發展的止血劑市場的關鍵市場洞察

供需的動態交互作用正在改變止血劑市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病的流行增加了手術介入的需要
    • 人們對微創手術的興趣日益濃厚
  • 市場限制因素
    • 產品召回增加
  • 市場機會
    • 基於生物聚合物的一次性止血劑的興起
    • 透過奈米技術的整合，實現更有效率、更有針對性的止血劑
  • 市場問題
    • 使用止血工具和試劑相關的感染和交叉污染的風險

波特的五力：駕馭止血劑市場的策略工具

波特的五力架構是了解止血劑市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解止血劑市場的外部影響

外部宏觀環境因素對止血劑市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解止血劑市場競爭格局

止血劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：止血劑市場供應商績效評估

FPNV定位矩陣是評估止血器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製止血劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，止血劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行增加了手術介入的需要
      • 微創手術日益成長
    • 抑制因素
      • 產品回收數量增加
    • 機會
      • 基於生物聚合物的一次性止血劑的興起
      • 奈米技術的整合創造了更有效率、更有針對性的止血劑
    • 任務
      • 使用止血工具和試劑相關的感染和交叉污染的風險
  • 市場區隔分析
    • 類型：由於減少出血的效果改善，擴大了合併止血劑的使用
    • 配方：粉狀止血劑在手術介入期間控制和預防出血的成長潛力
    • 應用：止血劑在心血管手術中預防失血、確保手術成功的重要作用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章止血劑市場：按類型

  • 介紹
  • 膠原蛋白止血劑
  • 混合止血劑
  • 明膠止血劑
  • 氧化再生纖維素系止血劑
  • 凝血酶止血劑

第7章止血劑市場：依配方

  • 介紹
  • 基質和凝膠
  • 粉末
  • 座椅和墊片
  • 海綿

第8章止血劑市場：依應用分類

  • 介紹
  • 心血管外科
  • 一般外科
  • 婦科手術
  • 神經外科
  • 整形外科
  • 重組手術

第9章美洲止血劑市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太止血劑市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲止血劑市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Teleflex 獲得 FDA核准在心臟手術中擴大 QuikClot Control+ 止血裝置的使用
    • 百特推出可吸收止血粉“PERCLOT”
    • Artivion 的 PerClot 獲得 FDA核准並開始轉移到 Baxter
    • Olympus Europa SE & Co. KG 擴大與 Endoclot 的合作關係，推出止血劑
    • Darling Ingredients 完成對巴西明膠和膠原蛋白製造商 Gelnex 的收購
    • 用於減少嚴重手術出血的幾丁聚醣止血劑已獲得 FDA 批准
    • Advamedica Inc 宣布 Ax-Surgi 手術止血器獲得 FDA 批准
    • Medcura 的 LifeGel 可吸收手術止血材料獲得突破性器械稱號
    • 美敦力公司的 Nexpasdar 內視鏡止血系統獲得美國FDA 批准
    • Hemostasis LLC 完成對 Fiagon Medical Technologies 的收購
  • 戰略分析和建議

公司名單

  • AR Medicom, Inc.
  • ACTEON Group
  • Advamedica Inc.
  • Advanced Medical Solutions Group PLC
  • Advin Health Care
  • Aegis Lifesciences Private Limited
  • Argon Medical Devices
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • Convatec Group PLC
  • Cook Group Incorporated
  • Cortis Medtech Pvt Ltd
  • Cotran Corporation
  • Dolphin Sutures by Futura Surgicare Pvt. Ltd.
  • Dynarex Corporation
  • Gelita AG
  • Hangzhou Singclean Medical Products Co.,Ltd.
  • Healthium Medtech Ltd
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medcura, Inc.
  • Medline Industries, LP
  • Medprin BIoTech GmbH
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Olympus Corporation
  • Pfizer Inc.
  • Rousselot BV by Darling Ingredients International Holding BV
  • Royal DSM
  • Shilpa Medicare Limited
  • Stapleline Medizintechnik GmbH
  • Stryker Corporation
  • SYMATESE
  • Teleflex Incorporated
  • Terumo Corporation
  • Zhejiang Perfectseal New Material Technology Co., Ltd.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-961BA04A2E36

The Hemostats Market was valued at USD 3.23 billion in 2023, expected to reach USD 3.42 billion in 2024, and is projected to grow at a CAGR of 5.65%, to USD 4.75 billion by 2030.

The scope and definition of hemostats pertain to medical devices or substances utilized to arrest bleeding in surgical and trauma scenarios by promoting the coagulation of blood. Hemostats are essential in both elective and emergency surgical procedures to enhance patient recovery times and outcomes, particularly in cardiovascular surgery, trauma care, and certain types of organ transplants. The end-use scope extends across hospitals, ambulatory surgical centers, and specialty clinics, with an increasing demand observed in military and trauma centers globally. Market insights reveal that the hemostats market is predominantly driven by a rise in surgical procedures, coupled with advancements in healthcare infrastructure, particularly in emerging economies. Technological innovations, such as the development of biodegradable hemostats and products suited for minimally invasive procedures, offer potential opportunities for businesses to expand their offerings. Key growth factors include an aging population, a rise in chronic conditions that necessitate surgical intervention, and increased healthcare spending across developing regions. However, substantial limitations persist, including stringent regulatory requirements, potential side effects, and the high cost of advanced hemostatic products, which may hinder market growth. Additionally, competition from alternative wound care and blood styptic products can negatively impact market expansion. The best areas for innovation include the development of next-generation hemostats with enhanced biocompatibility, faster action, and fewer adverse effects, as well as investment in research exploring the use of hemostats in novel surgical techniques. Additionally, creating sustainable, cost-effective solutions can broaden access in low-resource settings, providing untapped market potential. The competitive nature of the market demands strategic partnerships and collaborations with research institutions to stay ahead. In conclusion, while promising opportunities abound, companies must navigate regulatory landscapes and invest in R&D to address challenges and seize growth prospects effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 3.23 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemostats Market

The Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic disorders with increasing need for surgical interventions
    • Growing inclination toward minimally invasive surgeries
  • Market Restraints
    • Rising incidences of product recalls
  • Market Opportunities
    • Rise of biopolymer-based disposable hemostats
    • Integration of nanotechnology to create more efficient and targeted hemostats
  • Market Challenges
    • Risk of infection and cross contamination associated with the use of hemostats tools and reagents

Porter's Five Forces: A Strategic Tool for Navigating the Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemostats Market

A detailed market share analysis in the Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemostats Market

A strategic analysis of the Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, and Thrombin-Based Hemostats.
  • Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery, Orthopedic Surgery, and Reconstructive Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
    • 12.3.2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
    • 12.3.3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
    • 12.3.4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
    • 12.3.6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
    • 12.3.7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
    • 12.3.8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 12.3.9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
    • 12.3.10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A.R. Medicom, Inc.
  • 2. ACTEON Group
  • 3. Advamedica Inc.
  • 4. Advanced Medical Solutions Group PLC
  • 5. Advin Health Care
  • 6. Aegis Lifesciences Private Limited
  • 7. Argon Medical Devices
  • 8. B. Braun SE
  • 9. Baxter International Inc.
  • 10. Becton, Dickinson and Company
  • 11. Betatech Medical
  • 12. Convatec Group PLC
  • 13. Cook Group Incorporated
  • 14. Cortis Medtech Pvt Ltd
  • 15. Cotran Corporation
  • 16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
  • 17. Dynarex Corporation
  • 18. Gelita AG
  • 19. Hangzhou Singclean Medical Products Co.,Ltd.
  • 20. Healthium Medtech Ltd
  • 21. Hemostasis, LLC
  • 22. Integra LifeSciences Holdings Corporation
  • 23. Johnson & Johnson Services, Inc.
  • 24. Medcura, Inc.
  • 25. Medline Industries, LP
  • 26. Medprin Biotech GmbH
  • 27. Medtronic PLC
  • 28. Meril Life Sciences Pvt. Ltd.
  • 29. Olympus Corporation
  • 30. Pfizer Inc.
  • 31. Rousselot BV by Darling Ingredients International Holding B.V.
  • 32. Royal DSM
  • 33. Shilpa Medicare Limited
  • 34. Stapleline Medizintechnik GmbH
  • 35. Stryker Corporation
  • 36. SYMATESE
  • 37. Teleflex Incorporated
  • 38. Terumo Corporation
  • 39. Zhejiang Perfectseal New Material Technology Co., Ltd.
  • 40. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOSTATS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023